19 abril 2013

PharamaMar con Dos Farmacos ( Aplidin® y Zalypsis® ) . Research and Markets: Refractory Multiple Myeloma - Pipeline Review Analysis, H1 2013 .

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends

Companies Involved in Refractory Multiple Myeloma Therapeutics Development :



...